344-18790-76751
2 vaccinations
1 coded response
11 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 836 / ID
- Registered
- 2021-04-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-01
Registered in v-safe
-
2021-04-01
Dose 1 — Pfizer-BioNTech
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-05
-
2021-04-30
Dose 2 — Pfizer-BioNTech
-
2021-05-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-05-03
- 2021-05-04
-
2021-05-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Fatigue or tirednessAdult check-in
- 2021-05-07
- 2021-05-14
-
2021-10-31
Survey response — 6 months, dose 2MedDRA: Chills, Cough, Hyperhidrosis, Pyrexia — Feeling: PoorFree text: Low fever, chills, cough, sweats, etc.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Pfizer-BioNTech | |
| 2 | 2021-04-30 | Pfizer-BioNTech |
Free text
Release 10 — 6 months, dose 2
Symptoms: Low fever, chills, cough, sweats, etc.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Hyperhidrosis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release